This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Universitè De Montpellier, Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2016-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2016-2022
Title: Ollivier Milhavet: Innovator in Cellular Rejuvenation
Introduction
Ollivier Milhavet is a prominent inventor based in Montpellier, France. He has made significant contributions to the field of cellular rejuvenation, particularly through his innovative methods for reprogramming cells. With a total of 2 patents, Milhavet's work is paving the way for advancements in regenerative medicine.
Latest Patents
Milhavet's latest patents focus on a method for rejuvenating cells. This invention relates to a technique for reprogramming cells from aged donors or senescent cells into pluripotent cells that have lost the marks of senescence. Specifically, the method involves an ex vivo approach for preparing induced pluripotent stem cells (iPSCs) from a target cell population. The process includes culturing the target cell population under conditions that promote reprogramming, which involves increasing the expression of key reprogramming factors such as Oct4, Klf4, Sox2, c-Myc, Lin28, and optionally Nanog.
Career Highlights
Throughout his career, Milhavet has worked with esteemed institutions such as Université de Montpellier and the Institut National de la Santé et de la Recherche Médicale. His research has significantly impacted the understanding of cellular aging and rejuvenation.
Collaborations
Milhavet has collaborated with notable colleagues, including Alexandre Prieur and Jean-Marc Lemaitre. These partnerships have further enriched his research and contributed to the advancement of his innovative methods.
Conclusion
Ollivier Milhavet's work in cellular rejuvenation exemplifies the potential of innovative research in regenerative medicine. His contributions are vital for future developments in the field, and his patents reflect a commitment to advancing scientific knowledge.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile